Quite unexpectedly, a significant increase in Pd-l1 mRNA level was observed, and, according to the flow cytometry results, DNase I treatment resulted in an increase in the number of neutrophils with potential anti-tumor phenotype (FAS+ and PD-L1+) (Figure 5). The gene discussed is CD274; the disease is neoplasm.